CPA1 and pancreatic acinar cell carcinoma: Studies are needed to investigate whether the additional use of CELA3B will increase the diagnostic precision that can be achieved by using CPA1 [19], chymotrypsin [34], trypsin [34], or bcl10 [35] for diagnosing acinar cell carcinoma of the pancreas.